drugset
drugset / Trial / NCT01303510

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

NCT01303510 ↗

Phase 4 Completed 111 enrolled Crucell Holland BV
RandomizedParallel-groupOpen-labelTreatment

Summary

A study to assess whether the Northern Hemisphere 2008/2009 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines

Timeline

Start
2008-07
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Inflexal V Vaccine 0.5 ml Intramuscular

Indications

influenza